Replimune Group, Inc. (REPL)
NASDAQ: REPL · Real-Time Price · USD
10.61
+0.08 (0.76%)
At close: Dec 5, 2025, 4:00 PM EST
10.65
+0.04 (0.39%)
After-hours: Dec 5, 2025, 7:57 PM EST
Replimune Group Market Cap
Replimune Group has a market cap or net worth of $832.28 million as of December 5, 2025. Its market cap has increased by 11.09% in one year.
Market Cap
832.28M
Enterprise Value
584.96M
1-Year Change
11.09%
Ranking
Category
Stock Price
$10.61
Market Cap Chart
Since July 20, 2018, Replimune Group's market cap has increased from $467.51M to $832.28M, an increase of 78.02%. That is a compound annual growth rate of 8.12%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 925.43B |
| Johnson & Johnson | 494.70B |
| AbbVie | 406.92B |
| UnitedHealth Group | 307.72B |
| AstraZeneca | 283.29B |
| Novartis AG | 257.47B |
| Merck & Co. | 253.84B |
| Thermo Fisher Scientific | 218.08B |